Treatment of depression in type 2 diabetic patients: Effects on depressive symptoms, quality of life and metabolic control

Diabetes Research and Clinical Practice

Volumn 101, Issue 2, 2013, Pages 148-152

  Nicolau, Joana ^a   Rivera, Rosmeri ^a   Francés, Carla ^a   Chacártegui, Begoña ^a   Masmiquel, Lluís ^a  

^a HOSPITAL SON LLÀTZER   (Spain)

Author keywords

Citalopram; Depressive disorder; Quality of life; Type 2 diabetes

Indexed keywords

CITALOPRAM; HEMOGLOBIN A1C;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; BODY MASS; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DRUG DOSE INCREASE; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; QUALITY CONTROL; SHORT FORM 36; WAIST CIRCUMFERENCE;

EID: 84881241096     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2013.05.009     Document Type: Article

References (18)

1. Nouwen A., Winkley K., Twisk J., Lloyd C.E., Peyrot M., Ismail K., et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia 2010, 53:2480-2486.
2. Markowitz S.M., Gonzalez J.S., Wilkinson J.L., Safren S.A. A review of treating depression in diabetes: emerging findings. Psychosomatics 2011, 52:1-18.
3. Schram M.T., Baan C.A., Pouwer F. Depression and quality of life in patients with diabetes: a systematic review from the European depression in diabetes (EDID) research consortium. Curr Diab Rev 2009, 5:112-119.
4. Gonzalez J.S., Peyrot M., McCarl L.A., Collins E.M., Serpa L., Mimiaga M.J., et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diab Care 2008, 31:2398-2403.
5. Lustman P.J., Anderson R.J., Freedland K.E., de Groot M., Carney R.M., Clouse R.E. Depression and poor glycemic control: a meta-analytic review of the literature. Diab Care 2000, 23:934-942.
6. de Groot M., Anderson R., Freedland K.E., Clouse R.E., Lustman P.J. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001, 63:619-630.
7. Hutter N., Schnurr A., Baumeister H. Healthcare costs in patients with diabetes mellitus and comorbid mental disorders - a systematic review. Diabetologia 2010, 53:2470-2479.
8. Lustman P.J., Clouse R.E., Nix B.D., Freedland K.E., Rubin E.H., McGill J.B., et al. Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 2006, 63:521-529.
9. Paile-Hyvärinen M., Wahlbeck K., Eriksson J.G. Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: a single-blind randomised placebo controlled trial. BMC Fam Pract 2003, 4:7-10.
10. Lustman P.J., Freedland K.E., Griffith L.S., Clouse R.E. Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diab Care 2000, 23:618-623.
11. Amsterdam J.D., Shults J., Rutherford N., Schwartz S. Safety and efficacy of s-citalopram in patients with co-morbid major depression and diabetes mellitus. Neuropsychobiology 2006, 54:208-214.
12. Paile-Hyvärinen M., Wahlbeck K., Eriksson J.G. Quality of life and metabolic status in mildly depressed patients with type 2 diabetes treated with paroxetine: a double-blind randomised placebo controlled 6-month trial. BMC Fam Pract 2007, 8:34-37.
13. Goodnick P.J., Henry J.H., Buki V.M. Treatment of depression in patients with diabetes mellitus. J Clin Psychiatry 1995, 56:128-136.
14. Lustman P.J., Griffith L.S., Clouse R.E., Freedland K.E., Eisen S.A., Rubin E.H., et al. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med 1997, 59:241-250.
15. Ghaeli P., Shahsavand E., Mesbahi M., Kamkar M.Z., Sadeghi M., Dashti-Khavidaki S. Comparing the effects of 8-week treatment with fluoxetine and imipramine on fasting blood glucose of patients with major depressive disorder. Clin Psychopharmacol 2004, 24:386-388.
16. Erenmemisoglu A., Ozdogan U.K., Saraymen R., Tutus A. Effect of some antidepressants on glycaemia and insulin levels of normoglycaemic and alloxan-induced hyperglycaemic mice. J Pharm Pharmacol 1999, 51:741-743.
17. Moussavi S., Chatterji S., Verdes E., Tandon A., Patel V., Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007, 370:851-858.
18. Standards of medical care 2012. Diab Care 2012, 35(suppl.1):S1-S110. American Diabetes Association.